Search
HomeBusiness
Business

Takeda-led COVID-19 Plasma Product To Begin Trial This Month

25Views
Soumyadeep Pal
Coverage By Soumyadeep Pal

TOKYO: An experimental COVID-19 therapy using blood plasma, developed by Japan’s Takeda Pharmaceutical Co and its partners, is scheduled to begin a late-stage clinical trial after initial delays.

The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) in the United States, is seeking to recruit 500 participants from the United States, Britain, Argentina and Denmark, according to posting on a website run by the U.S. government’s National Institutes of Health (NIH).


The NIAID is an institute of the NIH.

The study, due to begin this month, seeks to compare outcomes from the plasma product to those from the drug Remdesivir and a placebo.

The Takeda-led group, known as the CoVIg-19 Plasma Alliance, had originally sought to begin trials in July. A Takeda representative said further questions about the study should be directed to the NIAID.

The institute did not immediately respond to a request for comment.

The alliance, which includes Biotest AG, CSL Behring, and Octapharma Plasma, is working on a hyperimmune globulin therapy derived from convalescent plasma. It offers a standardized dose of antibodies and does not need to be limited to patients with matching blood types.

Clinical supplies of the treatment were produced at Takeda’s facility in the U.S. state of Georgia and at CSL Behring’s facility in Bern, Switzerland.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor


Previous article
OPEC+ Panel To Meet Amid Oil Price Decline, Worry Of Virus Impact
Next article
Kiara Advani’s ‘Hasina Pagal Deewani’ song from Indoo Ki Jawani trends on YouTube – Watch

Speak Your Mind

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get in Touch

350FansLike
100FollowersFollow
281FollowersFollow
150FollowersFollow

Recommend for You

Oh hi there 👋
It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

We don’t spam! Read our privacy policy for more info.

You might also like

Startup & Funding

How to Make More Connections Through Referral Partners

By Chris Marin, founder at Convertist, which offers on-demand lead gen representatives and sales...
Soumyadeep Pal -
Business

Euro zone trade surplus surges as imports drop, GDP...

BRUSSELS The euro zone’s trade surplus with the rest of the world ballooned...
Soumyadeep Pal -
Business

These Industrial Robots Get More Adept With Every Task

Deep learning software makes sense of data like images or audio by looking...
Soumyadeep Pal -
Business

Rap Soars To Record As Streaming, Ed Sheeran Boost...

GLASTONBURY, ENGLAND - JUNE 28: Stormzy performs on the...
Soumyadeep Pal -

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

About Us

QNewsHub is your one stop destination for everything about business, science, technology, entertainment & reviews. We provide you with the latest breaking news and videos straight from the business, science, technology and entertainment industry from around the world.

Contact us: contact@qnewshub.com

Advertise with us: contact@qnewshub.com

Follow Us

Support Us & Be a Patreon

© 2024. QNewsHub Media | Check out our other awesome brand QNewsCrunch.